SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-024150
Filing Date
2018-10-11
Accepted
2018-10-11 16:24:38
Documents
6
Period of Report
2018-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bold-8k_20181009.htm 8-K 35538
2 EX-1.1 bold-ex11_8.htm EX-1.1 320401
3 EX-5.1 bold-ex51_6.htm EX-5.1 17208
4 EX-99.1 bold-ex991_7.htm EX-99.1 8755
5 GRAPHIC genz0sqlqm0y000001.jpg GRAPHIC 6659
6 GRAPHIC gksriviaurp2000001.jpg GRAPHIC 5248
  Complete submission text file 0001564590-18-024150.txt   399858
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37833 | Film No.: 181118556
SIC: 2836 Biological Products, (No Diagnostic Substances)